Depression and anxiety disorders remain among the most common and destabilizing health conditions worldwide. As the COVID-19 epidemic progresses, mental health has emerged as a principal concern, given the increase in social isolation, trauma exposure, and grief and bereavement, among other exposures. Today, Bryan James hosts a discussion with we talk with Katheleen Merikangas, Senior Investigator and Chief of the Genetic Epidemiology Research Branch in the Intramural Research Program at the National Institution on Mental Health, and Kerry Keyes Associate Professor from the Mailman School of Public Health at Columbia University, for a discussion of depression and anxiety – what these concepts mean, how and when they are clinically useful, and how we anticipate that COVID-19 will change the landscape of psychiatric diagnosis and treatment. https://www.ncbi.nlm.nih.gov/pubmed/30929042 https://www.ncbi.nlm.nih.gov/pubmed/18768940 https://www.ncbi.nlm.nih.gov/pubmed/31242010 https://www.ncbi.nlm.nih.gov/pubmed/30540352

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related